首页> Brain, behavior, and immunity> Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.

Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.

导出 OA

翻译打印收藏纠错

第一作者： Martial,Caillaud

第一单位： Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, USA. Electronic address: martial.caillaud@vcuhealth.org.

作者： Martial,Caillaud ^[1] ; Nipa H,Patel ^[2] ; Alyssa,White ^[2] ; Mackinsey,Wood ^[2] ; Katherine M,Contreras ^[2] ; Wisam,Toma ^[2] ; Yasmin,Alkhlaif ^[2] ; Jane L,Roberts ^[2] ; Tammy H,Tran ^[2] ; Asti B,Jackson ^[2] ; Justin,Poklis ^[2] ; David A,Gewirtz ^[2] ; M Imad,Damaj ^[3]

作者单位： Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, USA. Electronic address: martial.caillaud@vcuhealth.org. ^[1] Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, USA. ^[2] Department of Pharmacology and Toxicology and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, USA; Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, USA. Electronic address: m.damaj@vcuhealth.org. ^[3]

关键词 Chemotherapy Fibrates Neuroinflammation PPAR-?Peripheral neuropathy